MARETTI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.700
AS - Asia 4.825
EU - Europa 4.487
SA - Sud America 721
Continente sconosciuto - Info sul continente non disponibili 257
AF - Africa 108
OC - Oceania 50
Totale 20.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.371
SG - Singapore 1.433
IT - Italia 1.377
GB - Regno Unito 1.156
CN - Cina 1.155
VN - Vietnam 621
BR - Brasile 561
HK - Hong Kong 539
SE - Svezia 497
DE - Germania 314
BD - Bangladesh 236
FR - Francia 218
RU - Federazione Russa 207
IN - India 175
FI - Finlandia 173
CA - Canada 153
KR - Corea 137
UA - Ucraina 126
TR - Turchia 96
NL - Olanda 71
ID - Indonesia 70
JP - Giappone 66
BG - Bulgaria 65
AR - Argentina 64
BE - Belgio 63
MX - Messico 51
PL - Polonia 42
AU - Australia 40
IQ - Iraq 37
PK - Pakistan 32
ES - Italia 28
IR - Iran 28
IL - Israele 25
EC - Ecuador 24
ZA - Sudafrica 24
LT - Lituania 23
IE - Irlanda 22
AE - Emirati Arabi Uniti 21
PH - Filippine 20
CL - Cile 19
CO - Colombia 19
CR - Costa Rica 18
GT - Guatemala 18
KE - Kenya 17
MY - Malesia 17
TW - Taiwan 16
SV - El Salvador 15
MA - Marocco 14
HN - Honduras 13
JM - Giamaica 13
VE - Venezuela 13
AZ - Azerbaigian 12
TH - Thailandia 12
UZ - Uzbekistan 12
TT - Trinidad e Tobago 11
AT - Austria 10
CZ - Repubblica Ceca 10
EG - Egitto 10
NP - Nepal 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
CW - ???statistics.table.value.countryCode.CW??? 9
JO - Giordania 9
PR - Porto Rico 9
RS - Serbia 9
CH - Svizzera 8
HU - Ungheria 8
PE - Perù 8
RO - Romania 8
PT - Portogallo 7
PY - Paraguay 7
EE - Estonia 6
GP - Guadalupe 6
GR - Grecia 6
KZ - Kazakistan 6
MD - Moldavia 6
SA - Arabia Saudita 6
SC - Seychelles 6
BB - Barbados 5
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
GE - Georgia 5
NI - Nicaragua 5
EU - Europa 4
HR - Croazia 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
AL - Albania 3
BO - Bolivia 3
CI - Costa d'Avorio 3
LB - Libano 3
ML - Mali 3
MN - Mongolia 3
PA - Panama 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
Totale 19.867
Salva come PNG Salva come JPEG
Città #
Ashburn 1.178
Singapore 920
Santa Clara 862
Southend 721
Fairfield 571
San Jose 564
Chandler 541
Hong Kong 519
Council Bluffs 410
Woodbridge 356
Nyköping 257
Hefei 249
Beijing 242
Dearborn 241
Houston 235
Ann Arbor 225
Wilmington 218
Modena 213
Jacksonville 208
Ho Chi Minh City 196
Seattle 194
London 179
Cambridge 176
Los Angeles 165
Hanoi 153
New York 136
The Dalles 127
Helsinki 126
Seoul 120
Milan 113
Columbus 69
Princeton 66
Rome 63
Moscow 60
Chicago 59
Lauterbourg 58
Sofia 58
Dallas 55
San Diego 55
Bremen 53
Buffalo 53
Redwood City 51
Frankfurt am Main 50
Eugene 48
Shanghai 45
Fremont 44
Bologna 43
São Paulo 42
Tokyo 42
Izmir 40
Da Nang 38
Naples 37
Boardman 36
Brussels 36
Jakarta 36
Denver 34
Ottawa 34
Warsaw 33
Montreal 32
Atlanta 31
Orem 31
Phoenix 31
Munich 30
Chennai 26
Formigine 24
Haiphong 24
Mumbai 23
Parma 23
San Francisco 23
Mexico City 22
Porto Alegre 22
Rio de Janeiro 22
Amsterdam 20
Basingstoke 20
Sydney 19
Toronto 19
Falls Church 18
Guangzhou 18
Boston 16
Brooklyn 15
Charlotte 15
Dublin 15
Guatemala City 15
Hangzhou 15
New Delhi 15
Newark 15
North Bergen 15
Johannesburg 14
Saint Augustine 14
San José 14
Washington 14
Belo Horizonte 13
Nairobi 13
Nanjing 13
Napoli 13
Padua 13
Quito 13
Reggio Nell'emilia 13
San Salvador 13
Florence 12
Totale 12.539
Salva come PNG Salva come JPEG
Nome #
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 438
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 430
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 421
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 408
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 407
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 398
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 395
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 381
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 376
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 376
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 362
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 361
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 360
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 357
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 353
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 340
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 340
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 331
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 320
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 316
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 309
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 309
Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia 309
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 300
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 297
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 295
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 283
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 279
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 278
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 277
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 277
Formulazione per veicolare principi attivi lipofili 276
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 275
Aerodynamic performance of lipid-based nanocarrier functionalized by novel mannose derivatives for Rifampicin intramacrophagic delivery 275
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 275
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 274
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 267
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 260
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 257
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 256
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 249
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 240
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 237
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease 235
PASSIVE AND ACTIVE TARGETING TO MACROPHAGES USING LIPID NANOPARTICLES ASSEMBLIES FOR ANTI-TB THERAPY BY PULMONARY ROUTE 227
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 226
In vivo β-carotene skin permeation modulated by Nanostructured Lipid Carriers 222
Formulazione per veicolare principi attivi lipofili 222
Medicinal Chemistry drives drug targeted delivery: a successful interplay 212
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 208
Development of solid lipid nanoparticles for the delivery of an anti- inflammatory drug to muscle skeletal cells 207
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 201
Combination of Nanodelivery Systems and Constituents Derived from Novel Foods: A Comprehensive Review 198
Nasal biocompatible powder of geraniol oil complexed with cyclodextrins for neurodegenerative diseases: Physicochemical characterization and in vivo evidences of nose to brain delivery 198
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 194
Linking endocannabinoid system, palmitoylethanolamide, and sarcopenia in view of therapeutic implications 184
Inflammatory-Targeted Lipid Carrier as a New Nanomaterial to Formulate an Inhaled Drug Delivery System 181
Inhaled micro- or nanoparticles: which are the best for intramacrophagic anti-infectious therapies? 181
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 179
Design and physicochemical characterization of novel hybrid SLN-liposome nanocarriers for the smart co-delivery of two antitubercular drugs 178
APPLICATION OF A NEW SURFACTANT FOR INHALED ANTI-INFLAMMATORY DRUG DELIVERY SYSTEMS: FROM NANOCARRIER TO PURE NANODRUG FORMULATION 177
Palmitoylethanolamide-loaded Solid Lipid Nanoparticles for a therapeutic anti-inflammatory approach of Sarcopenia involving ECS 165
Dispositivo per la somministrazione intravaginale di batteri e loro metaboliti 161
Plant Resin Delivery by Nanovectors as an Emerging Approach to Boost Solubility, Permeability and Bioavailability 157
Nanoparticulate systems for the delivery of Palmitoylethanolamide to muscle cells 154
Investigating hybrid lipid-PLGA nanoparticles loaded with an endogenous endocannabinoid-like molecule for targeting inflamed muscle 139
Inhaled lipid nanoparticles: a feasible tool for a challenging route 138
Optimizing Formulation Conditions of PLGA Microparticles to Enhance Indomethacin Encapsulation 133
IMMOBILIZATION OF HEPARIN BY TERNARY POLYELECTROLYTE COMPLEXES: A PRELIMINARY STUDY 120
Investigating Hybrid PLGA-Lipid Nanoparticles as an Innovative Delivery Tool for Palmitoylethanolamide to Muscle Cells 115
New insights on Indomethacin and PLGA interaction for a rational design of microparticles to be administered via intra-articular route 115
Design and development of hybrid plga nanoparticles for the co-delivery of trimetazidine and palmitoylethanolamide for the treatment of sarcopenia 112
Lipid Nanodrugs for topical anti-inflammatory treatment of psoriasis: in vivo studies 110
Physicochemical characterization of SLN/Liposomes hybrid nanoparticles for the co-delivery of two antitubercular drugs: focus on SANS analysis 106
Smart nanodelivery of palmitoylethanolamide for topical treatment of inflammatory skin diseases 102
ENGINEERING OF DRUG DELIVERY SYSTEMS TO ENHANCE DRUG POTENTIAL: FROM BEADS TO POLYMER-FREE NANOPARTICLES 101
Comparative in vitro study of lipid and polymeric nanoparticles for the delivery of PEA to myoblasts. 98
Nanoparticle-mediated delivery to skeletal muscle cells of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule with anti-inflammatory properties 93
Development of a Heparin-Loaded Polyelectrolyte Complex for pH-Responsive Wound Healing Applications 93
Polymeric nanoparticles as a favorable delivery system to enhance the anti-inflammatory action of N-palmitoylethanolamide (PEA), an endocannabinoid-like molecule 86
Targeted Nanodrugs for Inhaled Therapy of Inflammatory Lung diseases 77
ENGINEERING A NANO‑OLEOGEL SYSTEM TO ENHANCE ORAL ADMINISTRATION OF PEA FOR ANTI‑INFLAMMATORY APPLICATIONS 71
Anti-inflammatory endocannabinoid-like molecule for topical and pulmonary administration: comparison between two different nano-delivery systems 48
Dual-Modulated Heparin Delivery from Electrospun PVA Nanofibers for Wound Healing: The Role of Polyelectrolyte Complexes and Fiber Crosslinking 42
Dual‑loaded nanoparticles targeting inflammation as multimodal strategy against sarcopenia 40
MULTIFUNCTIONAL HYBRID LIPID-PLGA NANOPARTICLES FOR DUAL DRUG DE-LIVERY: SURFACE FUNCTIONALIZATION WITH M12 PEPTIDE FOR MUSCLE TAR-GETING 33
Design of a new drug delivery system for the treatment of skin inflammatory diseases: smart delivery of palmitoylethanolamide 31
In vitro study emulating muscle response to stimuli exploiting 3D tissue model 28
Device for the intravaginal administration of bacteria and their metabolites 26
Totale 20.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 0 0 0 55 123 50 88 180 120 276 128
2022/20231.475 222 205 105 172 162 171 29 143 148 24 59 35
2023/2024863 34 67 69 94 174 106 70 74 18 28 50 79
2024/20253.311 78 30 118 227 601 429 311 249 359 156 342 411
2025/20266.021 389 199 432 559 785 388 914 388 671 644 374 278
2026/20272.597 206 631 755 833 172 0 0 0 0 0 0 0
Totale 20.148